Glaxosmithkline Llc Pac (Gsk Pac) OCT MONTHLY Filings
| Cycle | Date Filed | End Date | Amendment | Receipts | Spending | Cash |
|---|---|---|---|---|---|---|
| 2024 | Oct. 16, 2023 | Sept. 30, 2023 | $24,014.89 | $36,830.60 | $1,600.39 | |
| 2022 | Oct. 14, 2022 | Sept. 30, 2022 | $23,555.88 | $46,580.25 | $35,559.48 | |
| 2022 | Oct. 14, 2021 | Sept. 30, 2021 | $25,566.28 | $91,579.62 | $88,278.01 | |
| 2020 | Oct. 7, 2020 | Sept. 30, 2020 | $24,564.21 | $41,555.13 | $149,968.11 | |
| 2020 | Oct. 4, 2019 | Sept. 30, 2019 | $25,349.70 | $20,530.34 | $141,575.56 | |
| 2018 | Oct. 19, 2018 | Sept. 30, 2018 | $31,278.59 | $36,715.28 | $54,055.62 | |
| 2018 | Oct. 20, 2017 | Sept. 30, 2017 | $33,404.68 | $41,206.92 | $40,922.36 | |
| 2016 | Oct. 20, 2016 | Sept. 30, 2016 | $30,388.78 | $41,566.98 | $56,324.32 | |
| 2016 | Oct. 16, 2015 | Sept. 30, 2015 | $31,226.18 | $59,009.42 | $108,042.62 | |
| 2014 | Oct. 17, 2014 | Sept. 30, 2014 | $41,494.35 | $36,059.00 | $113,884.68 | |
| 2014 | Oct. 18, 2013 | Sept. 30, 2013 | $41,926.56 | $69,642.80 | $57,590.79 | |
| 2012 | Oct. 19, 2012 | Sept. 30, 2012 | $42,514.59 | $68,290.87 | $54,988.08 | |
| 2012 | Oct. 20, 2011 | Sept. 30, 2011 | $65,839.38 | $54,836.86 | $52,579.91 | |
| 2010 | Oct. 18, 2010 | Sept. 30, 2010 | $51,550.58 | -$10,558.71 | $105,693.31 | |
| 2010 | Oct. 19, 2009 | Sept. 30, 2009 | $64,701.81 | $118,934.00 | $301,625.36 | |
| 2008 | Sept. 18, 2009 | Sept. 30, 2008 | Compare to original | $72,818.90 | $108,562.00 | -$4,538.04 |
| 2008 | Sept. 18, 2009 | Sept. 30, 2007 | Compare to original | $77,943.70 | $122,800.00 | $191,854.00 |
| 2006 | Nov. 22, 2006 | Sept. 30, 2006 | View | View | ||
| 2006 | Oct. 13, 2005 | Sept. 30, 2005 | $82,703.90 | $101,527.00 | $433,430.00 | |
| 2004 | Oct. 11, 2004 | Sept. 30, 2004 | View | View | ||
| 2004 | Oct. 10, 2003 | Sept. 30, 2003 | $73,786.40 | $77,702.70 | $213,067.00 | |
| 2002 | Oct. 9, 2002 | Sept. 30, 2002 | View | View | ||
| 2002 | Oct. 18, 2001 | Sept. 30, 2001 | View | View |